Aggarwal, Rahul <br/><br/>
Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Aug 2014 
 - 359-65 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-014-2510-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Blood Glucose--analysis<br/>Female<br/>Follow-Up Studies<br/>Glycated Hemoglobin--metabolism<br/>Humans<br/>Insulin--metabolism<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Prognosis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Retrospective Studies<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases--antagonists & inhibitors